Neurodegenerative Diseases News and Research

RSS

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Research discusses the process of discovering anti-inflammatory and neuroprotective drugs from medicinal plants found in the Australian rainforest. It focuses on the pathways from the discovery of bioactive plants to the validation in an appropriate neuro-inflammatory mouse model, using some examples from their current research.

9 Jul 2023

Does the Mediterranean diet lower the incidence of type 2 diabetes among non-Mediterranean populations?

Researchers investigated the association between adherence to the Mediterranean diet and the prevalence of type 2 diabetes.

6 Jul 2023

EPFL scientists develop an innovative method for reconstructing Tau fibrils

EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer's disease and other neurodegenerative diseases.

4 Jul 2023

SPG-15: A Mother's Fight for a Gene Therapy Cure, Maddi's Story

News Medical spoke to the CEO and founder of the Maddi Foundation to gain a patient perspective on how important research in gene therapy is.

3 Jul 2023

Caffeine found to be most effective for treating birth asphyxia

Brain damage caused by oxygen deficiency at birth is one of the main causes of death in newborns worldwide. Using a small animal model, researchers from the University Hospital Bonn (UKB) and DZNE tested treatment with 25 different active agents.

3 Jul 2023

Novel engineered approach makes protein aggregates amenable to spatial manipulations in cells

Protein aggregates accumulate during aging and are linked to neurodegenerative diseases like Alzheimer's, Parkinson's or Huntington's disease.

30 Jun 2023

New method can track the complete activity of proteins in living cells

The genetic plans within our DNA come to functional fruition through proteins, which underlie our bodies' structure and activity.

29 Jun 2023

Promoting widespread use of brief assessment tools in primary care for early detection of cognitive impairment

Mild cognitive impairment, which occurs in about one in six individuals in the U.S., age 65 and older, remains substantially underdiagnosed, especially in disadvantaged populations.

29 Jun 2023

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

Have you ever felt the strong sensation that someone is behind you, so intense that you turn around, only to see that no-one is there? This is a 'presence hallucination'.

29 Jun 2023

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis.

28 Jun 2023

University Hospital Bonn and DZNE receive prestigious "Ataxia Center of Excellence" award

The Ataxia Center at the University Hospital Bonn (UKB) and DZNE have been awarded the title "Ataxia Center of Excellence" by the US National Ataxia Foundation (NAF) for their patient care and research – as the only organization in Europe.

26 Jun 2023

Study links poor sense of smell with increased risk of depression in older adults

In a study that followed more than 2,000 community-dwelling older adults over eight years, researchers at Johns Hopkins Medicine say they have significant new evidence of a link between decreased sense of smell and risk of developing late-life depression.

26 Jun 2023

The link between Covid-19 and Alzheimer's disease established

Renin-angiotensin system, or RAS, is a physiological mechanism essential to human body function. The SARS-CoV-2 virus causes overactivation and malfunction of this system.

21 Jun 2023

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

Alternative splicing, a clever way a cell generates many different variations of messenger RNAs -; single-stranded RNAs involved in protein synthesis -; and proteins from the same stretch of DNA, plays an important role in molecular biology.

21 Jun 2023

UJI and UE set up a Joint Research Unit in neurodegenerative diseases

The Universitat Jaume I of Castelló (UJI) and the Universidad Europea (UE) in Madrid have set up a Joint Research Unit in neurodegenerative diseases to carry out scientific activities and projects in this field that favor excellent research and high-impact scientific results.

19 Jun 2023

Neurodevelopmental disruptions could pave the way for Alzheimer's disease

In the cerebral cortex, neurogenesis – the formation of neural cells from stem cells – begins in the fetus from 5 weeks gestation and is almost complete by 28 weeks.

16 Jun 2023

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

New research from Boston Medical Center found a significant correlation between biomarkers in the vitreous humor of the eye and pathologically confirmed cases of Alzheimer's disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue.

16 Jun 2023

Aging impacts cellular composition across the whole fly: Study

As the body ages, organ function progressively declines and the risk for a wide range of diseases, including cardiovascular disease, cancer and neurodegenerative diseases, increases. Understanding how the body ages is an intense area of research as it will potentially illuminate ways to promote healthy aging.

16 Jun 2023

Gut microbiota holds clues to predicting Alzheimer's risk

Gut microbiome alterations in preclinical Alzheimer's disease (AD) were investigated, revealing distinct taxonomic composition and potential markers of AD risk. These findings contribute to understanding AD pathology and offer insights into gut-derived markers for AD.

15 Jun 2023

Detailed 3D images of the synapse offer precise geometry of interactions between individual cells

Scientists have created one of the most detailed 3D images of the synapse, the important juncture where neurons communicate with each other through an exchange of chemical signals. These nanometer scale models will help scientists better understand and study neurodegenerative diseases such as Huntington's disease and schizophrenia.

15 Jun 2023

Neurodegenerative Diseases News and Research

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Does the Mediterranean diet lower the incidence of type 2 diabetes among non-Mediterranean populations?

EPFL scientists develop an innovative method for reconstructing Tau fibrils

SPG-15: A Mother's Fight for a Gene Therapy Cure, Maddi's Story

Caffeine found to be most effective for treating birth asphyxia

Novel engineered approach makes protein aggregates amenable to spatial manipulations in cells

New method can track the complete activity of proteins in living cells

Promoting widespread use of brief assessment tools in primary care for early detection of cognitive impairment

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

University Hospital Bonn and DZNE receive prestigious "Ataxia Center of Excellence" award

Study links poor sense of smell with increased risk of depression in older adults

The link between Covid-19 and Alzheimer's disease established

Alternative splicing in neurodegenerative disease and the promise of RNA-based therapeutic strategies

UJI and UE set up a Joint Research Unit in neurodegenerative diseases

Neurodevelopmental disruptions could pave the way for Alzheimer's disease

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

Aging impacts cellular composition across the whole fly: Study

Gut microbiota holds clues to predicting Alzheimer's risk

Detailed 3D images of the synapse offer precise geometry of interactions between individual cells

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News